系统生物学方法用于识别用于治疗COVID-19的驱动基因和药物组合
Ali Ebrahimi1, Farinaz Roshani2
1Department of Physics, Alzahra University, Tehran, Iran.
Scientific reports
|January 26, 2024
概括
这项研究使用网络分析确定了驱动COVID-19进展的关键基因. 研究结果揭示了不同的基因表达模式,并表明了潜在的药物点,用于更好的治疗策略.
科学领域:
- * 病毒学和生物信息学
- * 基因组学和系统生物学
背景情况:
- *2019年新型冠状病毒病 (COVID-19) 在全球面临重大公共卫生挑战.
- *尽管有大量的研究和OMIC数据,但有效的早期诊断和综合治疗仍然难以捉摸.
- * 现有的治疗策略缺乏对驱动疾病进展的潜在分子机制的深入理解.
研究的目的:
- * 确定涉及COVID-19病变发生的关键枢纽和驱动基因.
- *分析COVID-19患者与对照者的基因表达模式和相关性.
- * 提出基于药物基因相互作用的潜在治疗干预措施.
主要方法:
- * 蛋白质与蛋白质相互作用 (PPI) 网络和信号通路的网络分析.
- *中心性和可控制性分析以确定关键基因.
- *差异基因表达分析和相关性模式评估.
- *药物基因相互作用映射以确定潜在的治疗剂.
主要成果:
- * 确定重要的枢纽和驱动基因,这些基因对COVID-19的发展和进展至关重要.
- *在COVID-19患者和健康对照者之间,关键基因的显著差异表达的证明.
- *观察明显的基因表达相关性模式,表明疾病状态.
- *为潜在的组合疗法开发一个两部分图表,说明药物基因相互作用.
结论:
- * 已识别的基因是COVID-19病变发生过程中的关键参与者.
- * 基因表达和相关性模式中的独特分子特征突出显示了疾病机制.
- * 拟议的药物基因相互作用为开发新型COVID-19治疗提供了一个有希望的途径.
相关概念视频
Structure-Activity Relationships and Drug Design
721
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
721
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


